Memphasys

Memphasys ROA

The Return on Assets (ROA) of Memphasys (MEM.AX) as of Oct 19, 2026 is -36.52 %. In the previous year, Return on Assets (ROA) was -44.84 % — a change of -18.55% (higher).

ROA

-36.52 %

YoY

-18.55%

Last updated:

In 2026, Memphasys's return on assets (ROA) was -36.52 %, a -18.55% increase from the -44.84 % ROA in the previous year.

The Memphasys ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2019
-15.28 AUD
Jan 1, 2020
-10.04 AUD
Jan 1, 2021
-10.19 AUD
Jan 1, 2022
-14.74 AUD
Jan 1, 2023
-23.20 AUD
Jan 1, 2024
-35.74 AUD
Jan 1, 2025
-44.84 AUD
Jan 1, 2026
-36.52 AUD
The Memphasys ROA history
YEARROAYoY
-36.52 %-18.55%
-44.84 %+25.47%
-35.74 %+54.05%
-23.20 %+57.34%
-14.74 %+44.62%
-10.19 %+1.58%
-10.04 %-34.32%
-15.28 %+60.63%
-9.51 %-65.27%
-27.39 %-9.39%
-30.23 %-12.33%
-34.48 %-36.26%
-54.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Memphasys Stock analysis

What does Memphasys do? Memphasys Ltd, listed on the Australian Securities Exchange under the ticker MEM.AX, is a life sciences company headquartered in Homebush West, New South Wales. The company went public via an IPO on May 14, 2007. Memphasys operates within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company focuses on developing medical devices, diagnostics, and media for applications in assisted reproduction technology (ART) for both humans and animals. Its product pipeline includes several developments, such as Felix, ROSA, and AI-Port. Felix is a patented, automated device designed to separate high-quality sperm from semen for human in vitro fertilization (IVF) procedures, aiming to avoid DNA damage. ROSA functions as an in vitro diagnostic tool to evaluate semen and blood samples for oxidative stress. AI-Port is a system for storing and transporting animal semen for artificial insemination (AI) in livestock, capable of maintaining semen viability for up to four days without freezing, which is a common practice in standard AI procedures. The company's products target global markets, particularly in the field of reproductive biotechnology, with specific applications in both human and animal reproductive health. Memphasys operates with a focus on innovation in reproductive technology, leveraging proprietary media and diagnostic tools to address challenges in assisted reproduction. Memphasys is one of the most popular companies on Eulerpool.

ROA Details

Understanding Memphasys's Return on Assets (ROA)

Memphasys's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Memphasys's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Memphasys's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Memphasys’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Memphasys stock

Return on Assets (ROA) of Memphasys is -36.52 % in 2026.

Return on Assets (ROA) of Memphasys changed from -44.84 % to -36.52 %, representing a -18.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Memphasys since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Memphasys with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Memphasys

All Key Metrics — Memphasys